Login / Signup

Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy.

Kelly J GaffneyJames A DavisMary McGannKathy EdwardsZaheer AhmedColleen ButcherBrian GreenwellBrian T HessHamza Hashmi
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Early use of tocilizumab and corticosteroids is effective in preventing excessive CAR-T-related toxicities with no negative impact on efficacy.
Keyphrases
  • juvenile idiopathic arthritis
  • body mass index
  • weight gain
  • bone marrow
  • stem cells
  • mesenchymal stem cells
  • rheumatoid arthritis patients
  • physical activity
  • replacement therapy